Amalgamated Financial’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Amalgamated Financial’s Portfolio THRN Stock Details THRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$7K	Buy	+1,027	New	+$5.53K	﹤0.01%	2944

Other funds holding THRN

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return

Amalgamated Financial's THRN Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Thorne Healthtech, Inc. Common Stock (THRN) in Q1 2022: 1,027 shares worth $7K. The stake represents ﹤0.01% of the portfolio and ranks #2944 among its holdings.

48 funds tracked by Wall St. Rank hold THRN as of Q1 2022.

Amalgamated Financial held 1,027 shares of Thorne Healthtech, Inc. Common Stock worth $7K as of Q1 2022.
Thorne Healthtech, Inc. Common Stock was a new Amalgamated Financial position in Q1 2022.
Thorne Healthtech, Inc. Common Stock made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2944 holding.
48 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.